Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC50 Values against MDR S. epidermidis

Authors:

Abstract
Clofazimine (CLZ) is an antibiotic with promising behavior against gram positive bacteria however the drug is completely insoluble in water and accumulates in fat tissues. We explored nanocarriers, labeled and not with rhodamine, consisting of negatively charged sulfobutylether-β-cyclodextrins for CLZ loading. A new oligomeric carrier was obtained crosslinking βCyD with epichlorohydrin followed by sulfonation in strongly alkaline aqueous medium. The oligomeric carrier has MW of 53 kDa, and forms small nanoparticles of few tens of nm. With aqueous solutions containing 25 mg/ml oligomeric carrier we loaded up to 0.5 mg/ml drug. The oligomeres exhibit a tenfold better loading capacity compared to monomers and nanoparticles with size in the 20-60 nm range after drug loading. Circular dichroism confirmed encapsulation of the CLZ in the nanocarriers. All carriers with or without CLZ are not cytotoxic up to 1 M, while CLZ alone is highly cytotoxic at the same concentration. The drug has IC50 values below 100 nM against S. epidermidis. The same holds also for clinical isolates of S epidermidis, some displaying MDR. So, the selectivity index significantly increased for CLZ/carrier systems compared to the drug alone. Taken all together our results open new avenues for the clinical application of this antibiotic.
Funding Information
  • FP7 People: Marie-Curie Actions (608407)

This publication has 41 references indexed in Scilit: